New Products Now Eligible for Medi-Cal

We’re excited to announce that our newest products will be available for Medi-Cal beneficiaries. Per the California Department of Health Care Services Pharmacy Benefits Division, these Kate Farms formulas will be added to the approved Medi-Cal List of Enteral Nutrition Products effective July 1, 2021:

  • Kate Farms® Pediatric Peptide 1.5 Plain
  • Kate Farms® Peptide 1.0 Vanilla/Plain
  • Kate Farms® Peptide 1.5 Vanilla
  • Kate Farms® Standard 1.0 Plain

In addition to these formulas already available:

  • Kate Farms® Pediatric Peptide 1.0 Vanilla
  • Kate Farms® Pediatric Peptide 1.5 Vanilla
  • Kate Farms® Pediatric Standard 1.2 Vanilla
  • Kate Farms® Peptide 1.5 Plain
  • Kate Farms® Standard 1.0 Vanilla/Chocolate
  • Kate Farms® Standard 1.4 Vanilla/Plain

Kate Farms has the broadest offering of plant-based formulas with a full range of peptide formulas for children and adults. All Kate Farms formulas are made for tolerance with easily digested organic pea protein, soluble fiber and phytonutrients to support gut health, and without common allergens or artificial ingredients. These formulas are clinically proven to demonstrate improved tolerance and weight gain in children and adults.1-5

New product ordering information:

Download PDF

1. Bailey, M., Millovich, V., Komar, S. Weight gain in oncology patients using a plant-based oral nutrition supplement. Clinical Nutrition ESPEN. 2020; 40:661.

2. Cohen, SA., et al. Improved GI tolerance and weight gain in pediatric patients using plant-based enteral formulas. JPEN. 2020; 44(3):274.

3. Cohen, SA., et al. Patient-reported outcomes indicate plant-based enteral formula improves nutrition and gastrointestinal symptoms. JPEN. 2020; 44(3):275.

4. Orellana, D., et al. Plant-based enteral nutrition tolerance and benefit in pediatric Crohn’s disease: A case series. JPEN. 2020; 44(3):190-191.

5. Bailey, M., et al. Plant-based peptide enteral nutrition with phytonutrients in a pediatric patient status post bone marrow transplant: A case report. JPEN. 2020; 44(3):226-227.